QUEEN MARY UNIVERSITY OF LONDON

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private

Established: 1882-01-08

Employees: 1K

Market Cap: -

Website: http://www.qmul.ac.uk

Clinical Trials

Telaprevir in Genotype 3 HCV

Phase 4

Completed

Conditions: Hepatitis C

Interventions: Drug: Telaprevir
Drug: 40 Kd Pegylated interferon alfa 2a
Drug: Ribavirin

First Posted Date: 2014-03-14

Last Posted Date: 2023-01-05

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 14

Registration Number: NCT02087111

Locations: 🇬🇧
Nottingham University Hospitals Trust, Nottingham, United Kingdom
🇬🇧
Bradford Teaching Hospitals NHS Foundation Trust, Bradford, United Kingdom
🇬🇧
Ste Georges Healthcare NHS Trust, London, United Kingdom

and more 1 locations

Treatment of Iron Deficiency Anaemia in Inflammatory Bowel Disease With Ferrous Sulphate

Phase 4

Completed

Conditions: Ulcerative Colitis
Crohn's Disease

Interventions: Drug: Ferrous sulphate

First Posted Date: 2013-11-25

Last Posted Date: 2017-05-09

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 90

Registration Number: NCT01991314

Locations: 🇬🇧
Barts Health NHS Trust, London, United Kingdom

Improving Lower Limb Blood Flow in Healthy Adult Volunteers

Early Phase 1

Completed

Conditions: Deep Vein Thrombosis

Interventions: Device: geko

First Posted Date: 2013-11-11

Last Posted Date: 2013-11-11

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 50

Registration Number: NCT01981733

Locations: 🇬🇧
St. Bartholomew's Hospital, London, United Kingdom

Heart Attack Prevention Programme for You (HAPPY) London

Not Applicable

Completed

Conditions: Cardiovascular Disease

Interventions: Behavioral: Electronic coaching plus standard care

First Posted Date: 2013-07-30

Last Posted Date: 2020-10-12

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 402

Registration Number: NCT01911910

Locations: 🇬🇧
Centre for Advanced Cardiovascular Imaging, William Harvey Research Institute, Queen May University of London, London, United Kingdom

UK-Czech E-cigarette Study

Not Applicable

Completed

Conditions: Smoking Cessation

Interventions: Other: Standard care plus electronic cigarettes
Behavioral: Standard care

First Posted Date: 2013-04-30

Last Posted Date: 2019-09-04

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 199

Registration Number: NCT01842828

Locations: 🇬🇧
Tobacco Dependence Research Unit, Queen Mary University of London, London, United Kingdom

A School-based Education Programme to Reduce Salt Intake in Children and Their Families

Not Applicable

Completed

Conditions: Healthy Volunteer

Interventions: Behavioral: Salt reduction
Other: Control

First Posted Date: 2013-03-29

Last Posted Date: 2023-01-10

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 832

Registration Number: NCT01821144

Locations: 🇨🇳
Changzhi Medical College, Changzhi, Shanxi, China

A Study Comparing AZD2014 vs Everolimus in Patients With Metastatic Renal Cancer

Phase 2

Terminated

Conditions: Metastatic Clear Cell Renal Carcinoma

Interventions: Drug: AZD2014
Drug: Everolimus

First Posted Date: 2013-02-15

Last Posted Date: 2014-06-24

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 49

Registration Number: NCT01793636

Locations: 🇬🇧
Royal Sussex County Hospital, Brighton, United Kingdom
🇬🇧
Royal Bournemouth Hospital, Bournemouth, United Kingdom
🇬🇧
University Hospitals Coventry & Warwickshire NHS Trust, Coventry, United Kingdom

and more 6 locations

Raltegravir (Isentress) Pilot Study in Relapsing Multiple Sclerosis

Phase 2

Completed

Conditions: Relapsing Remitting Multiple Sclerosis

Interventions: Drug: Raltegravir

First Posted Date: 2013-01-14

Last Posted Date: 2017-05-30

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 23

Registration Number: NCT01767701

Locations: 🇬🇧
The Royal London Hospital, London, United Kingdom

Long-term Anastrozole Versus Tamoxifen Treatment Effects

Completed

Conditions: Breast Cancer

First Posted Date: 2012-12-10

Last Posted Date: 2019-07-10

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 2671

Registration Number: NCT01745289

Locations: 🇬🇧
Queen Mary University of London, London, England, United Kingdom

Comparison of Pulmonary Vein Isolation Using SmartTouch® Catheter With or Without Real-time Contact Force Data

Not Applicable

Completed

Conditions: Atrial Fibrillation
Pulmonary Vein Isolation
Atrial Fibrillation Ablation

Interventions: Procedure: Pulmonary vein isolation using contact force sensing catheter

First Posted Date: 2012-11-21

Last Posted Date: 2016-09-29

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 120

Registration Number: NCT01730924

Locations: 🇬🇧
Barts Health NHS Trust, London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy